Cite
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study
MLA
Blagojevic, Jelena, et al. Use of Vasoactive/Vasodilating Drugs for Systemic Sclerosis (SSc)-Related Digital Ulcers (DUs) in Expert Tertiary Centres: Results from the Analysis of the Observational Real-Life DeSScipher Study. Jan. 2020. EBSCOhost, https://doi.org/10.5167/uzh-171469.
APA
Blagojevic, J., Abignano, G., Avouac, J., Cometi, L., Frerix, M., Bellando-Randone, S., Guiducci, S., Bruni, C., Huscher, D., Jaeger, V. K., Lóránd, V., Maurer, B., Nihtyanova, S., Riemekasten, G., Siegert, E., Tarner, I. H., Vettori, S., Walker, U. A., Czirják, L., … EUSTAR co-workers. (2020). Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study. https://doi.org/10.5167/uzh-171469
Chicago
Blagojevic, Jelena, Giuseppina Abignano, Jérôme Avouac, L Cometi, Marc Frerix, Silvia Bellando-Randone, Serena Guiducci, et al. 2020. “Use of Vasoactive/Vasodilating Drugs for Systemic Sclerosis (SSc)-Related Digital Ulcers (DUs) in Expert Tertiary Centres: Results from the Analysis of the Observational Real-Life DeSScipher Study,” January. doi:10.5167/uzh-171469.